| How accurately do maize crop models simulate the interactions of atmospheric CO2 concentration levels with limited water supply on water use and yield? JL Durand, K Delusca, K Boote, J Lizaso, R Manderscheid, HJ Weigel, ... European journal of agronomy 100, 67-75, 2018 | 111 | 2018 |
| Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma A Baraniskin, E Zaslavska, S Nöpel-Dünnebacke, G Ahle, S Seidel, ... Neuro-oncology 18 (3), 361-367, 2015 | 46 | 2015 |
| Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma F Strehlow, S Bauer, P Martus, M Weller, P Roth, U Schlegel, S Seidel, ... Journal of neuro-oncology 129, 165-171, 2016 | 39 | 2016 |
| Have treatment protocols for primary CNS lymphoma advanced in the past 10 years? S Seidel, U Schlegel Expert review of anticancer therapy 19 (10), 909-915, 2019 | 20 | 2019 |
| Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication S Seidel, T Wehner, D Miller, J Wellmer, U Schlegel, W Grönheit Neurological Research and Practice 4 (1), 45, 2022 | 19 | 2022 |
| MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial T Tzaridis, N Schäfer, J Weller, JP Steinbach, U Schlegel, S Seidel, ... International journal of cancer 148 (7), 1695-1707, 2021 | 19 | 2021 |
| Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma S Seidel, H Pels, S Schlömer, A Kowoll, K Fliessbach, A Engert, ... Neurology 95 (23), e3138-e3144, 2020 | 18 | 2020 |
| Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study L Dirven, R Luerding, D Beier, E Bumes, C Reinert, C Seidel, ... Journal of neuro-oncology 148, 117-130, 2020 | 17 | 2020 |
| HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a … S Seidel, A Korfel, T Kowalski, M Margold, F Ismail, R Schroers, ... Neurological Research and Practice 1, 1-9, 2019 | 14 | 2019 |
| Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma T Mika, S Ladigan, A Baraniskin, D Vangala, S Seidel, O Hopfer, M Kiehl, ... Haematologica 105 (4), e160, 2020 | 13 | 2020 |
| Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding DM Waldera-Lupa, O Etemad-Parishanzadeh, M Brocksieper, ... Oncotarget 8 (66), 110118, 2017 | 13 | 2017 |
| The value of bone marrow biopsy for staging of patients with primary CNS lymphoma M Margold, S Seidel, T Kowalski, S Ladigan-Badura, A Baraniskin, ... Neuro-oncology 23 (12), 2076-2084, 2021 | 10 | 2021 |
| Screening for psychiatric comorbidities and psychotherapeutic assessment in inpatient epilepsy care: preliminary results of an implementation study R Michaelis, S Schlömer, A Lindemann, V Behrens, W Grönheit, M Pertz, ... Frontiers in Integrative Neuroscience 15, 754613, 2021 | 10 | 2021 |
| HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series S Seidel, T Kowalski, M Margold, A Baraniskin, R Schroers, P Martus, ... Therapeutic advances in neurological disorders 13, 1756286420951087, 2020 | 10 | 2020 |
| Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis J Kuhnhenn, T Kowalski, S Steenken, K Ostermann, U Schlegel Journal of neuro-oncology 109, 433-438, 2012 | 9 | 2012 |
| A multiplex assay for the stratification of patients with primary central nervous system lymphoma using targeted mass spectrometry DM Waldera-Lupa, G Poschmann, N Kirchgaessler, ... Cancers 12 (7), 1732, 2020 | 8 | 2020 |
| High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma: a retrospective monocentric analysis of long-term … S Seidel, V Nilius-Eliliwi, T Kowalski, DB Vangala, U Schlegel, R Schroers Cancers 14 (9), 2100, 2022 | 7 | 2022 |
| Patients with primary central nervous system lymphoma not eligible for clinical trials: prognostic factors, treatment and outcome S Seidel, M Margold, T Kowalski, A Baraniskin, R Schroers, A Korfel, ... Cancers 13 (12), 2934, 2021 | 6 | 2021 |
| Complete response to therapy: why do primary central nervous system lymphoma patients not return to work? G Wiemann, M Pertz, T Kowalski, S Seidel, U Schlegel, P Thoma Journal of Neuro-Oncology 149, 171-179, 2020 | 5 | 2020 |
| Complications of intracerebroventricular chemotherapy via subgaleal reservoir in primary central nervous system lymphoma: A single‐institution experience on 1247 installations … S Anton, M Margold, T Kowalski, D Miller, K Schmieder, U Schlegel, ... Hematological Oncology 39 (2), 176-184, 2021 | 4 | 2021 |
